As CD36 promotes uptake and accumulation of oxidized-lipids and thereby T-cell dysfunctions, its systemic or CD8+ T cell-specific deletion slows down tumor growth, and rejuvenates antitumor functions of infiltrated CD8+ T cells by preventing oxidized LDL-dependent lipid peroxidation [116]. The gene discussed is CD8A; the disease is neoplasm.